16 results for “synthetic-cannabinoids”
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over […]
The ‘legal high’ Hexahydrocannabinol, better known as HHC, is on the rise across Europe. Here’s what you need to know.
The Citizens’ Assembly was established in February to examine and make recommendations on the country’s drug policy.
UK company, Chanelle McCoy Health, has been granted ethics approval in Australia for a clinical trial investigating the effect of its synthetic CBD formulation on sleep. The pharmaceutical company has […]
Home Office officials have acknowledged that the current regulations may be holding back research.
An open letter urges the government to rethink proposals for harsher drug policies.
A Canadian cannabis company is set to study minor cannabinoids for the treatment of epilepsy as part of a National Institute of Health (NIH) programme. Cannabis research company, Cannabis Orchards, […]
A new hemp-based high is on the rise in Europe, but is it safe?
Selected cannabinoid and terpenes have the potential to reduce inflammation associated with a range of health conditions.
Louis Petit has been seizure-free for two years on medical cannabis.
Researchers in the US have been investigating whether the effects are the same.
The test could play a critical role in efforts to stop the spread of these drugs, say researchers.
A former police officer has shared cannabis has helped him reclaim his life after a diagnosis of PTSD
Synthetic cannabinoids appear to have less appeal in states which have legalised natural cannabis.
Cannabinoid acetates are non-natural compounds found in some synthetic cannabis products.
A new report highlights the public health and social risks posed by synthetic cannabinoids
